What is the recommended treatment for herpangina in children?

Herpangina Treatment in Children

Herpangina is a self-limited viral illness requiring only supportive care—no specific antiviral therapy is routinely recommended, and treatment focuses on symptom management with adequate hydration, soft diet, and topical pain relief.

Core Treatment Approach

Supportive Care (Mainstay of Treatment)

• Adequate hydration is essential, as oral intake is often reduced due to painful oral lesions 1
• Dietary modifications: Exclude salty, spicy, and fried foods that may irritate oral lesions 2
• Restriction of physical activity during the acute phase 2
• Avoid thermal procedures that may worsen symptoms 2

Symptomatic Management

• Topical oral sprays for pain relief are the primary pharmacologic intervention 1
• Benzydamine spray (0.255 mg/dose, 6 doses 3 times daily, on demand) can provide local analgesia 2
• Treatment is primarily symptomatic, as the disease course is self-limited 1, 3

Disease Course and Prognosis

• Duration: The illness generally lasts 4-6 days with excellent prognosis 1
• Oral lesions: Rarely persist more than 7 days 3
• Complete resolution: Typically occurs within 10 days from onset 2

Antiviral Considerations

Evidence for Specific Antivirals

While some studies have evaluated antiviral agents, the evidence remains limited:

• Interferon α-2b spray showed better efficacy than ribavirin in one randomized trial, with 98.5% of patients achieving fever resolution within 72 hours versus 94.3% with ribavirin 4
• Inosine pranobex (Groprinosin) at 50 mg/kg/day has been used in clinical practice, though evidence is primarily from case reports 2

However, these agents are not standard of care, and the Chinese expert consensus emphasizes that treatment incorporates topical oral spray with antiviral drugs only as adjunctive therapy, not primary treatment 1

Key Clinical Pitfalls to Avoid

• Do not prescribe broad-spectrum systemic antivirals routinely—the disease is self-limited and supportive care is sufficient 1
• Do not confuse with bacterial pharyngitis—diagnosis is based on characteristic pharyngeal vesicles/ulcers, epidemiology, and viral etiology (Coxsackievirus-A, Enterovirus-A, Echovirus) 1
• Monitor for complications: While rare, viral throat infections may accompany skin manifestations like erythema multiforme 3
• Ensure adequate follow-up: Patients should show clinical improvement within the expected 4-6 day timeframe 1

Diagnostic Confirmation

• Clinical diagnosis is typically sufficient based on characteristic pharyngeal damage and epidemiologic history 1
• Virological testing (PCR) can confirm diagnosis when needed 2
• The disease primarily affects young children, with average age of onset around 2.5 years 4